Compass Therapeutics (NASDAQ:CMPX) stock gains as its oncology drug tovecimig hits main goal in a Phase 2/3 trial for biliary ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Consortium announced the launch of its official website, creating a central hub for information about its initiatives and clinical research studies. ALL-ALS.org is designed to inform and engage ...

You may have heard about using magnesium for anxiety, but does it actually work? Learn about the benefits and drawbacks of ...

Image Credit: ALIOUI MA / Shutterstock In a recent study published ... When interpreting results, the authors emphasized that metformin, the comparator, may itself reduce cancer risk, which ...

VCAR33 clinical data update planned for first half of 2025 and trem-cel + Mylotarg clinical data update planned for second ...

“What we’re going to take away from this study is that we get a new hypothesis as to what the shark looks like and that its body mass was probably not quite as chunky as we thought it was.

The data demonstrated durable engraftment, shielding from Mylotarg on-target toxicity, a broadened Mylotarg therapeutic window, and early evidence of improved relapse-free survival compared to ...

Remember, the MA contracts are not ours ... we're looking to do this as a -- with a standard-of-care comparator and kind of discussing with the agency, the -- how we'll analyze that data and ...